TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 57 filers reported holding TALARIS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $97,306 | -2.2% | 32,009 | -39.5% | 0.06% | -6.3% |
| Q1 2023 | $99,445 | +144.4% | 52,896 | +32.6% | 0.06% | +125.0% |
| Q4 2022 | $40,689 | -49.8% | 39,891 | +29.9% | 0.03% | -51.7% |
| Q3 2022 | $81,000 | +52.8% | 30,715 | +163.0% | 0.06% | +52.6% |
| Q2 2022 | $53,000 | – | 11,677 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $5,513,299 | 6.67% |
| BML Capital Management, LLC | 1,929,484 | $3,627,430 | 3.14% |
| Western Standard LLC | 586,481 | $1,102,584 | 1.12% |
| Cormorant Asset Management, LP | 900,649 | $1,693 | 0.11% |
| Artal Group S.A. | 914,262 | $1,719 | 0.10% |
| Values First Advisors, Inc. | 52,896 | $99,445 | 0.06% |
| Blackstone Inc. | 8,089,315 | $15,207,912 | 0.06% |
| Eventide Asset Management | 1,561,092 | $2,934,853 | 0.05% |
| Marquette Asset Management, LLC | 101,375 | $190,585 | 0.05% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $6,184,480 | 0.03% |